Last reviewed · How we verify
NCT07016555
Burning Mouth Syndrome: Symptoms and Management
EARLY_PHASE1 trial testing Oral cooling spray in Burning Mouth Syndrome in 50 participants. Currently enrolling.
31 August 2025
Quick facts
| Lead sponsor | University of Massachusetts, Amherst |
|---|---|
| Phase | EARLY_PHASE1 |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | none |
| Primary purpose | supportive care |
| Enrollment | 50 |
| Start date | 11 June 2025 |
| Primary completion | 31 August 2025 |
| Estimated completion | 15 December 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Oral cooling spray
Conditions studied
- Burning Mouth Syndrome — all drugs for Burning Mouth Syndrome →
Sponsor
University of Massachusetts, Amherst
Who can join
18 and older, any sex, with Burning Mouth Syndrome. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This research study aims to evaluate how an oral cooling spray, currently a commercial dietary supplement, impacts symptoms associated with burning mouth syndrome (BMS). This study will examine symptoms, frequency, and severity, along with other related side effects of BMS on food intake, enjoyment, and quality of life.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07016555
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Burning Mouth Syndrome
Currently open trials in the same condition.
- NCT07381361 — Photobiomodulation Therapy vs. Alpha-Lipoic Acid in Burning Mouth Syndrome Treatment · NA · active not recruiting
- NCT06040190 — Effect of Treatments on Pain and Quality of Life in Individual With Burning Mouth Syndrome · Phase 4 · recruiting
- NCT05819697 — Reducing Patient Memory Recall in the Burning Mouth Patient Population · recruiting
Other University of Massachusetts, Amherst trials
Trials by the same sponsor.
- NCT07211373 — Advancing Student Suicide Interventions With Scalable Technologies · NA · enrolling by invitation
- NCT06990997 — Effects of Aphasia Identification Cards on Service Workers' Comprehension of People With Aphasia · NA · recruiting
- NCT06412016 — Urban Gardening and Peer Nutritional Counseling for People With HIV and Food Insecurity · NA · active not recruiting
- NCT06399939 — The Function of Biphasic Sleep in Infants · NA · recruiting
- NCT05949866 — Feasibility and Fidelity of a Gross Motor-based Physical Activity Intervention on Cognition in Preschool-age Children · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07016555 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University of Massachusetts, Amherst
- Last refreshed: 11 June 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07016555.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing